BROADCASTS.com

b'Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children. The technology allows for the enhanced delivery of anti-cancer drugs to the specific locations of brain tumors while sparing normal brain regions.Dr. Praveen Raju,\\xa0Co-Director of the Children\\u2019s Brain and Spinal Tumor Center at Mount Sinai Kravis Children\\u2019s Hospital (New York), joins us today to discuss the development of a novel approach to enhance drug delivery for brain tumors in children.\\xa0Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children. The technology allows for the enhanced delivery of anti-cancer drugs to the specific locations of brain tumors while sparing normal brain regions.'